Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
QuintilesIMS
US Army
Cipla
Farmers Insurance
Covington
Daiichi Sankyo
Julphar
Colorcon

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207304

« Back to Dashboard

NDA 207304 describes INCASSIA, which is a drug marketed by Aurobindo Pharma Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the INCASSIA profile page.

The generic ingredient in INCASSIA is norethindrone. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
Summary for 207304
Tradename:INCASSIA
Applicant:Aurobindo Pharma Ltd
Ingredient:norethindrone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Pharmacology for NDA: 207304
Ingredient-typeProgesterone Congeners
Medical Subject Heading (MeSH) Categories for 207304
Suppliers and Packaging for NDA: 207304
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INCASSIA norethindrone TABLET;ORAL-28 207304 ANDA Aurobindo Pharma Limited 65862-925 65862-925-92 6 POUCH in 1 CARTON (65862-925-92) > 1 TABLET in 1 POUCH
INCASSIA norethindrone TABLET;ORAL-28 207304 ANDA Aurobindo Pharma Limited 65862-925 65862-925-88 3 POUCH in 1 CARTON (65862-925-88) > 1 TABLET in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.35MG
Approval Date:Sep 23, 2016TE:AB1RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Federal Trade Commission
Cerilliant
McKinsey
Chinese Patent Office
Argus Health
Accenture
Fish and Richardson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot